Published Research | April 2022

All Published Papers by Month

April 26, 2022

  1. Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome – Clinical Infectious Diseases

April 19, 2022

  1. Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older – JAMA

April 12, 2022

  1. Occupation and COVID-19 diagnosis, hospitalisation and ICU admission among foreign-born and Swedish-born employees: a register-based study – BMJ
  2. Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis – The Lancet
  3. Multisystem Inflammatory Syndrome in a Young Adult Following COVID-19 Infection: A Case Report – Cureus

April 8, 2022

  1. Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization – JAMA
  2. Protection by a Fourth Dose of BNT162b2 against Omicron in Israel – NEJM
  3. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study – The Lancet

April 5, 2022

  1. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 – CDC

April 1, 2022

  1. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden – The Lancet
  2. The Concept of Classical Herd Immunity May Not Apply to COVID-19 – Journal of Infectious Diseases
  3. Effect of Early Treatment with Ivermectin among Patients with Covid-19 – NEJM
All Published Papers by Month